Rebecca Epperly

420 total citations
30 papers, 241 citations indexed

About

Rebecca Epperly is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Rebecca Epperly has authored 30 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Public Health, Environmental and Occupational Health and 11 papers in Hematology. Recurrent topics in Rebecca Epperly's work include CAR-T cell therapy research (15 papers), Acute Lymphoblastic Leukemia research (9 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Rebecca Epperly is often cited by papers focused on CAR-T cell therapy research (15 papers), Acute Lymphoblastic Leukemia research (9 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Rebecca Epperly collaborates with scholars based in United States. Rebecca Epperly's co-authors include Stephen Gottschalk, Mireya Paulina Velasquez, Abishek Vaidya, Sujuan Huang, Nirali N. Shah, Cheng Cheng, Aimee C. Talleur, Masayuki Umeda, Jeffery M. Klco and Sagar L. Patil and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rebecca Epperly

26 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca Epperly United States 7 171 83 72 59 40 30 241
Madison J. Kelly Australia 4 157 0.9× 98 1.2× 117 1.6× 33 0.6× 39 1.0× 7 251
Guillermo O. Rangel Rivera United States 10 185 1.1× 117 1.4× 169 2.3× 41 0.7× 22 0.6× 18 337
Dana Průková Czechia 7 149 0.9× 139 1.7× 53 0.7× 28 0.5× 40 1.0× 14 296
Luca Basso‐Ricci Italy 7 121 0.7× 145 1.7× 104 1.4× 90 1.5× 77 1.9× 9 314
Peter Gambell Australia 6 136 0.8× 91 1.1× 86 1.2× 46 0.8× 118 3.0× 11 264
Jessica Hulitt United States 3 82 0.5× 59 0.7× 79 1.1× 41 0.7× 44 1.1× 4 187
Nasheed Hossain United States 8 176 1.0× 61 0.7× 32 0.4× 64 1.1× 18 0.5× 24 272
Adele Mucci Germany 10 80 0.5× 180 2.2× 158 2.2× 67 1.1× 26 0.7× 18 404
Amirhosein Maali Iran 7 85 0.5× 98 1.2× 48 0.7× 21 0.4× 26 0.7× 26 219
Brent Chick United States 4 207 1.2× 189 2.3× 140 1.9× 48 0.8× 29 0.7× 9 357

Countries citing papers authored by Rebecca Epperly

Since Specialization
Citations

This map shows the geographic impact of Rebecca Epperly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Epperly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Epperly more than expected).

Fields of papers citing papers by Rebecca Epperly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Epperly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Epperly. The network helps show where Rebecca Epperly may publish in the future.

Co-authorship network of co-authors of Rebecca Epperly

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Epperly. A scholar is included among the top collaborators of Rebecca Epperly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Epperly. Rebecca Epperly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ying, Challice L. Bonifant, Rebecca Epperly, et al.. (2024). EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapy. Blood Advances. 9(2). 270–279. 6 indexed citations
2.
Epperly, Rebecca, Emily Zeng, Renee Madden, et al.. (2024). Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy. Transplantation and Cellular Therapy. 30(5). 526.e1–526.e11.
3.
Epperly, Rebecca, Swati Naik, Brandon M. Triplett, et al.. (2024). Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent, and young adult patients with B-cell acute lymphoblastic leukemia. Pediatric Nephrology. 39(8). 2495–2503. 7 indexed citations
4.
Epperly, Rebecca, Stephen Gottschalk, & Christopher DeRenzo. (2024). CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives. SHILAP Revista de lepidopterología. 3. 100160–100160. 7 indexed citations
5.
6.
Sun, Yilun, Li Tang, Aimee C. Talleur, et al.. (2024). Risk-Adapted Donor Lymphocyte Infusion after Hematopoietic Cell Transplant in Pediatric and Young Adult Patients Is Associated with Low Risk of Graft Versus Host Disease. Transplantation and Cellular Therapy. 30(2). S401–S401.
7.
Epperly, Rebecca, Barry L. Shulkin, Asim K. Bag, et al.. (2023). CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALL. Blood Advances. 7(20). 6320–6324. 3 indexed citations
8.
Wu, Diana, Ying Li, Deborah Ward, et al.. (2023). Outcomes following intolerance to calcineurin inhibitor‐based graft‐versus‐host disease prophylaxis in children after allogeneic hematopoietic cell transplantation. Pediatric Blood & Cancer. 70(9). e30517–e30517. 1 indexed citations
9.
Epperly, Rebecca & Nirali N. Shah. (2023). Long-term follow-up of CD19-CAR T-cell therapy in children and young adults with B-ALL. Hematology. 2023(1). 77–83. 5 indexed citations
10.
Levine, Deena R., Rebecca Epperly, Aimee C. Talleur, et al.. (2023). Integration of Palliative Care in Hematopoietic Cell Transplant: Pediatric Patient and Parent Needs and Attitudes. Journal of Pain and Symptom Management. 66(3). 248–257. 2 indexed citations
11.
Epperly, Rebecca, et al.. (2023). Early and Late Toxicities of Chimeric Antigen Receptor T-Cells. Hematology/Oncology Clinics of North America. 37(6). 1169–1188. 6 indexed citations
12.
13.
McNerney, Kevin O., Emily M. Hsieh, Haneen Shalabi, et al.. (2023). INSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent Toxicities. Transplantation and Cellular Therapy. 30(1). 38–55. 14 indexed citations
14.
Pfeiffer, Thomas, Ying Li, Seth E. Karol, et al.. (2022). Venetoclax-Based Combination Therapy As a Bridge to Allogeneic Hematopoietic Stem Cell Transplant in Children with Relapsed/Refractory AML. Transplantation and Cellular Therapy. 28(3). S120–S121. 2 indexed citations
15.
Epperly, Rebecca, Aimee C. Talleur, Jean‐Yves Métais, et al.. (2022). Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients. Transplantation and Cellular Therapy. 28(5). 262.e1–262.e10. 1 indexed citations
16.
Hebbar, Nikhil, Rebecca Epperly, Abishek Vaidya, et al.. (2022). CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells. Nature Communications. 13(1). 587–587. 66 indexed citations
17.
Marón, Gabriela, Diego R. Hijano, Rebecca Epperly, et al.. (2022). Infectious Complications in Pediatric, Adolescent and Young Adult Patients Undergoing CD19-CAR T Cell Therapy. Frontiers in Oncology. 12. 845540–845540. 15 indexed citations
18.
Epperly, Rebecca, Stephen Gottschalk, & Mireya Paulina Velasquez. (2020). A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy. Frontiers in Oncology. 10. 262–262. 67 indexed citations
19.
Sequeira, Gina M., et al.. (2018). Improving the Evaluation and Management of Abnormal Uterine Bleeding in Female Adolescents Presenting for Emergency Care. Journal of Pediatric and Adolescent Gynecology. 32(2). 128–134. 2 indexed citations
20.
Williams, A. Lynn, et al.. (1999). Treatment Efficacy in Phonological Intervention: Clinical Case Studies. Digital Commons - East Tennessee State University (East Tennessee State University). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Madison J. Kelly Breakdown of academic impact, for papers by Guillermo O. Rangel Rivera Breakdown of academic impact, for papers by Dana Průková Breakdown of academic impact, for papers by Luca Basso‐Ricci Breakdown of academic impact, for papers by Peter Gambell Breakdown of academic impact, for papers by Jessica Hulitt Breakdown of academic impact, for papers by Nasheed Hossain Breakdown of academic impact, for papers by Adele Mucci Breakdown of academic impact, for papers by Amirhosein Maali Breakdown of academic impact, for papers by Brent Chick
Rankless by CCL
2026